Genesis DNA
Cambridge
About Genesis DNA
Genesis DNA is taking a fundamentally new approach to gene synthesis, the process of turning digital text like ACTG into physical DNA. Their proprietary method circumvents the cost, turnaround time, and sequence limiting factors of existing synthesis methods. Genesis was founded by a team of students at Stanford and MIT that have experienced the pain of current DNA construction methods first hand. They started Genesis DNA with the vision that every researcher should have fast, affordable, and secure access to any DNA sequence they need. They believe the next technology revolution will be a biological one.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $250.0K
- Funding stage: Seed
- Last round: Seed (Sep 2015)
- Website: genesisdna.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/genesis-dna-2770721 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.